Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Viavi Solutions
VIAV
$9.12B
| $37.8M | 0.01% |
2,525,052
-1,074,324
| -30% | -$14.3M |
|
1127
PUT
Viatris
VTRS
$20.4B
| $37.8M | 0.01% |
2,017,748
+613,348
| +44% | +$10M |
|
|
1128
CALL
Analog Devices
ADI
$179B
| $37.8M | 0.01% |
255,900
-123,900
| -33% | -$16.4M |
|
1129
CALL
Newmont
NEM
$98.7B
| $37.8M | 0.01% |
630,756
-69,544
| -10% | -$4.29M |
|
1130
BioXcel Therapeutics
BTAI
$24.9M
| $37.6M | 0.01% |
50,890
+4,039
| +9% | +$3.15M |
|
1131
First Trust Enhanced Short Maturity ETF
FTSM
$6.49B
| $37.6M | 0.01% |
625,664
+515,722
| +469% | +$31M |
|
1132
MacroGenics
MGNX
$235M
| $37.5M | 0.01% |
1,641,261
+1,068,686
| +187% | +$24.6M |
|
1133
PUT
iShares US Real Estate ETF
IYR
$4.66B
| $37.5M | 0.01% |
438,000
-30,000
| -6% | -$2.5M |
|
1134
MongoDB
MDB
$27.1B
| $37.5M | 0.01% |
104,454
-176,941
| -63% | -$49.4M |
|
|
1135
PUT
Newmont
NEM
$98.7B
| $37.5M | 0.01% |
625,952
-126,448
| -17% | -$7.79M |
|
1136
PUT
Cleveland-Cliffs
CLF
$6.57B
| $37.3M | 0.01% |
2,563,040
-34,360
| -1% | -$348K |
|
1137
PUT
VanEck Oil Services ETF
OIH
$2.06B
| $37.3M | 0.01% |
242,275
-84,925
| -26% | -$10.8M |
|
1138
PUT
Akamai
AKAM
$16.7B
| $37.2M | 0.01% |
354,400
+109,600
| +45% | +$11.5M |
|
1139
Graco
GGG
$12.9B
| $37.2M | 0.01% |
514,117
+314,881
| +158% | +$21.1M |
|
1140
PUT
Rocket Companies
RKT
$36.5B
| $37.2M | 0.01% |
1,839,200
+371,800
| +25% | +$7.85M |
|
1141
iShares Short Maturity Bond ETF
NEAR
$4.83B
| $37.2M | 0.01% |
740,619
-47,780
| -6% | -$2.4M |
|
1142
8x8 Inc
EGHT
$269M
| $37.1M | 0.01% |
1,077,250
+781,778
| +265% | +$16.8M |
|
|
MRSH
1143
Marsh
MRSH
$90.5B
| $37.1M | 0.01% |
317,330
+241,079
| +316% | +$27.4M |
|
|
ABMD
1144
PUT
DELISTED
Abiomed Inc
ABMD
| $37M | 0.01% |
114,100
+16,600
| +17% | +$4.59M |
|
1145
Invesco
IVZ
$13.1B
| $36.9M | 0.01% |
2,119,295
+1,318,801
| +165% | +$20.3M |
|
1146
PUT
Plug Power
PLUG
$2.87B
| $36.8M | 0.01% |
1,085,600
+394,300
| +57% | +$8.93M |
|
1147
PPG Industries
PPG
$24.6B
| $36.8M | 0.01% |
+255,130
| New | +$35.5M |
|
1148
Guardant Health
GH
$21.7B
| $36.7M | 0.01% |
284,887
+44,351
| +18% | +$5.1M |
|
|
MZTI
1149
The Marzetti Company
MZTI
$2.93B
| $36.6M | 0.01% |
199,111
-32,768
| -14% | -$5.71M |
|
1150
PUT
Strategy Inc
MSTR
$34.1B
| $36.6M | 0.01% |
941,000
+817,000
| +659% | +$19.1M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.